MONDAY, MAY 22, 2017

Labcyte Genomics Symposium Edinburgh: US Department of Energy Joint Genome Institute

At the US Department of Energy Joint Genome Institute, scientists are applying new technologies to investigate microbial function in extreme environments, including the deep ocean, sub-sea floor hydrothermal vents, geothermal hot springs and sub-glacial lakes.

Read More

TUESDAY, MAY 09, 2017

Labcyte Genomics Symposium Edinburgh: John Innes Centre, UK

The John Innes Centre in Norwich, UK, presented information about the Engineering Nitrogen Symbiosis for Africa (ENSA) project at our recent Genomics Symposium in Edinburgh. The aim of the projects, according to Dr. Andy Breakspear, is to integrate the molecular pathways from legumes into cereal crops for better affordability and sustainability.

Read More


Labcyte Genomics Symposium Edinburgh: GeneMill Foundry in Liverpool

The team at SelectScience covered our Genomics Symposium in Edinburgh, providing summaries of the great talks presented by our customers. This is the first of a series of posts with links to those summaries. Each contains a link to the full presentation video hosted by SelectScience.

Read More

MONDAY, APRIL 24, 2017

Labcyte Genomics Symposium Edinburgh: Imperial College London | SynbiCITE

SynbiCITE is the Innovation and Knowledge Centre (IKC) for Synthetic Biology at Imperial College in London. You can watch the video or read a summary of their presentation at our Genomics Symposium courtesy of SelectScience.

Read More


See You at AACR 2017!

If you are attending the American Association for Cancer Research (AACR) Annual Meeting in Washington, DC, April 1 - 5, stop by and see us at BOOTH #2614!

Read More


Labcyte's Road to Commercialization - an Interview with Mark Fischer-Colbrie at PMWC Silicon Valley 2017

The recent PMWC Silicon Valley event held in late January at the Computer History Museum in Mountain View, CA, boasted 10,000 attendees and 1,500 speakers. Topics at the event ran the gamut from patent and law policies, economics and emerging technologies to clinical enablement and genomic data analysis. One of our favorite sessions was an onstage discussion between Alex De Winter of GE Ventures and our CEO, Mark Fischer-Colbrie. Titled “How to Commercialize Technologies that Advance PM,” their conversation focused on Labcyte’s path to monetization and commercialization in the realm of precision medicine.

Read More

MONDAY, MARCH 06, 2017

Labcyte Named "20 Most Promising Biotech Technology Solution Provider" by CIO Magazine

Labcyte was featured on the cover of CIO Magazine as one of the "20 Most Promising Biotech Technology Solution Providers 2017." A four-page article about the company, based on their interview with our CEO Mark Fischer-Colbrie, is included with the issue. The article covers an overview of our Echo liquid handling systems and the many ways it is having an impact in the biotechnology and pharmaceutical industries.

Read More